Azimilide

File:Heartpotential.jpg

Azimilide is a class III antiarrhythmic agent that is used to treat various types of cardiac arrhythmias. It works by blocking specific ion channels in the heart, which helps to stabilize the cardiac rhythm.

Mechanism of Action

Azimilide functions primarily by blocking the potassium channels in the heart. This action prolongs the action potential duration and the effective refractory period of the cardiac cells. By doing so, it helps to prevent abnormal electrical activity that can lead to arrhythmias.

Clinical Uses

Azimilide is used in the management of several types of arrhythmias, including:

• Atrial fibrillation
• Atrial flutter
• Ventricular tachycardia
• Ventricular fibrillation

Pharmacokinetics

Azimilide is administered orally and is well-absorbed from the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily through the kidneys. The drug has a relatively long half-life, which allows for once-daily dosing.

Side Effects

Common side effects of azimilide include:

• Nausea
• Dizziness
• Headache
• Fatigue

Serious side effects may include:

• Torsades de pointes
• Prolonged QT interval
• Bradycardia

Contraindications

Azimilide is contraindicated in patients with:

• Severe hepatic impairment
• Severe renal impairment
• Congenital long QT syndrome

Drug Interactions

Azimilide can interact with other medications that prolong the QT interval, such as:

• Amiodarone
• Sotalol
• Quinidine

Research and Development

Azimilide has been the subject of various clinical trials to evaluate its efficacy and safety in the treatment of cardiac arrhythmias. Ongoing research aims to better understand its long-term effects and potential new therapeutic applications.

See Also

• Antiarrhythmic agent
• Cardiac arrhythmia
• Potassium channel blocker

External Links

• 
  Azimilide